DI SALVO, CLELIA
 Distribuzione geografica
Continente #
EU - Europa 343
NA - Nord America 208
AS - Asia 89
AF - Africa 16
OC - Oceania 1
Totale 657
Nazione #
US - Stati Uniti d'America 207
IT - Italia 195
AT - Austria 41
SG - Singapore 40
SE - Svezia 33
CN - Cina 32
DE - Germania 18
GB - Regno Unito 15
FR - Francia 10
PL - Polonia 10
BG - Bulgaria 9
CI - Costa d'Avorio 8
CH - Svizzera 6
HK - Hong Kong 5
SN - Senegal 5
JP - Giappone 4
CZ - Repubblica Ceca 3
TR - Turchia 3
FI - Finlandia 2
NG - Nigeria 2
PH - Filippine 2
VN - Vietnam 2
AU - Australia 1
CA - Canada 1
DZ - Algeria 1
IN - India 1
NL - Olanda 1
Totale 657
Città #
Milan 47
Pisa 40
Vienna 29
Chandler 28
Ashburn 24
Singapore 20
Boardman 19
Chicago 19
New York 16
London 13
Santa Clara 11
Florence 9
Abidjan 8
Frankfurt am Main 7
Munich 7
Sofia 7
Warsaw 7
Livorno 6
Marseille 6
Naples 6
Seattle 6
Columbus 5
Dakar 5
Hong Kong 5
Ogden 5
Bremen 4
Fairfield 4
Lawrence 4
Medford 4
Princeton 4
Rome 4
Brno 3
Cambridge 3
Dallas 3
Istanbul 3
Palermo 3
Serra 3
Żyrardów 3
Bern 2
Brookings 2
Caldiero 2
Coreglia Antelminelli 2
Dong Ket 2
Lagos 2
Lappeenranta 2
Los Angeles 2
Lumino 2
Montegiordano 2
Nagoya 2
Padova 2
Pietrasanta 2
Pleven 2
Quanzhou 2
Shanghai 2
Tagliacozzo 2
Taranto 2
Valenzuela 2
Verona 2
Zurich 2
Barking 1
Brescia 1
Capaccio 1
Fuzhou 1
Groningen 1
Marino 1
Otemae 1
Ottawa 1
Paris 1
Perano 1
Pune 1
Rapallo 1
Shenzhen 1
Washington 1
Wilmington 1
Woodbridge 1
Wuhan 1
Totale 459
Nome #
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice 101
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 97
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 88
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis 85
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 78
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 70
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 66
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 39
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 25
Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology (npj Parkinson's Disease, (2022), 8, 1, (9), 10.1038/s41531-021-00263-x) 18
Gut-directed therapy in Parkinson’s disease 11
Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis 6
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 4
Totale 688
Categoria #
all - tutte 3.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/202257 0 0 0 5 8 6 4 2 8 8 5 11
2022/2023216 18 26 14 10 22 23 4 18 38 22 15 6
2023/2024277 19 25 38 16 43 35 10 11 5 9 22 44
2024/2025133 22 19 28 45 19 0 0 0 0 0 0 0
Totale 688